Vanadium Chloro-Substituted Schiff Base Catecholate Complexes are Reducible, Lipophilic, Water Stable, and Have...

Area of Science:

• Inorganic Chemistry
• Medicinal Chemistry
• Materials Science

Background:

• Schiff base catecholate vanadium complexes exhibit promising anticancer properties.
• Hydrophobic and stable complexes are desirable for therapeutic applications.
• Existing vanadium complexes may have limitations in stability or efficacy.

Purpose of the Study:

• Synthesize and characterize novel chloro-substituted Schiff base vanadium(V) complexes.
• Compare their anticancer activity against human glioblastoma cells with existing compounds.
• Investigate structure-activity relationships and stability of these complexes.

Main Methods:

• Synthesis of three new chloro-substituted Schiff base vanadium(V) complexes.
• Characterization using NMR (51V, 1H), UV-vis spectroscopy, mass spectrometry, and electrochemistry.
• In vitro testing on T98g human glioblastoma cells to determine IC50 values.

Main Results:

• Geometric isomers were identified and characterized in solution.
• The most sterically hindered and hydrophobic complex showed superior in vitro anticancer activity (IC50 = 4.1 ± 0.5 μM).
• Chloro-substituted complexes demonstrated enhanced hydrophobicity, stability, and reducibility compared to non-chlorinated counterparts.

Conclusions:

• Novel chloro-substituted Schiff base vanadium(V) complexes possess potent in vitro anticancer activity.
• The most sterically hindered complex is significantly more effective than cisplatin against glioblastoma cells.
• These findings highlight the potential of these vanadium complexes for developing new brain cancer therapeutics.